Standard Biotools Inc
LAB
$0.66-4.17%
End of day · as of Oct 12, 2026, 4:01 PM ET
Mkt cap
$317.12M
EV/Sales
2.30
P/E ratio
N/A
FY2025 Revenue
$85.33M
EPS (H1 2026)
$0.26
Gross Margin (FY2025)
49.86%
Profit Margin (FY2025)
-87.77%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported LAB revenue for 2025-12-31 was $85.3M. Net income was -$74.9M. Revenue was down 51.1% from 2024-12-31 to 2025-12-31. LAB currently screens at market cap $317.1M.
Use this LAB research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full LAB income, balance, and cash tables.
Standard Biotools Inc (LAB) is a medical devices company in the Healthcare sector.
Latest cached Standard Biotools Inc (LAB) revenue for Dec 31, 2025 was $85.3M. Net income was -$74.9M. Statements: https://lician.com/financials/lab
Standard Biotools Inc (LAB) market capitalization is $317.1M on the latest cached snapshot.
Standard Biotools Inc (LAB) cached previous close $0.69; day range $0.66 – $0.69; volume 432,460. Session quote: https://lician.com/quote/lab
Standard Biotools Inc (LAB) latest cached earnings event is "LAB earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached LAB filing is 8-K · Oct 5, 2026. Filings: https://lician.com/sec/lab